NCT05741229View on ClinicalTrials.gov

The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

January 20, 2025

Conditions
Persistent Pulmonary Hypertension of the NewbornEchocardiographyRespiratory Disease
Interventions
DRUG

Nebulized nitroglycerine as adjunctive therapy

Patients with PPHN will have nebulized nitroglycerine as adjunctive therapy

DRUG

conventional therapy for PPHN

patients will receive sildenafil which is used routinely in management of PPHN in our unit, in addition to appropriate oxygenation and ventilation.

Trial Locations (1)

0325

Alexandria University, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT05741229 - The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns | Biotech Hunter | Biotech Hunter